依卡倍特钠联合西咪替丁对胃溃疡患者血清多肽类激素及细胞因子水平的影响

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the effect of Ecabet Sodium combined with Cimetidine on the levels of serum peptide hormones and cytokines in patients with gastric ulcer. Methods A total of 82 patients with gastric ulcer in Zhongshan Chen Xinghai Hospital from February 2020 to August 2021 were selected as the study subjects and divided into control group (41 cases) and observation group (41 cases) by random number table method. The control group was treated with Cimetidine, and the observation group was treated with Ecabet Sodium for 4 weeks. The clinical efficacy, serum peptide hormones (motilin [MTL], gastrin [GAS], somatostatin [SS]), cytokine levels (vascular endothelial growth factor[VEGF], epidermal growth factor [EGF], interleukin-1 [IL-1]) and the total incidence of adverse reactions were compared between the two groups. Results The total effective rate of treatment in the observation group was higher than that in the control group, the difference was statistically significant (P＜0.05). After treatment, the serum MTL and GAS in the observation group were lower than those in the control group, SS, VEGF, and RGF were higher than those in the control group, and IL-1 was lower than that in the control group, the differences were statistically significant (P＜0.05).There was no statistical difference in the total incidence of adverse events between the two groups (P＞0.05). Conclusion Ecabet Sodium combined with Cimetidine in the treatment of gastric ulcer can effectively improve the levels of serum peptide hormones and cytokines in patients, improve clinical efficacy, and is safe and reliable.

Key words： Gastric ulcer Ecabet Sodium Cimetidine Serum peptide hormones Cytokines

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	GUO Yanfen
	SU Zhiyu
	XIAO Meihua

Cite this article:

GUO Yanfen,SU Zhiyu,XIAO Meihua. Effect of Ecabet Sodium combined with Cimetidine on serum peptide hormones and cytokines in patients with gastric ulcer[J]. 中国当代医药, 2022, 29(16): 155-157.

URL:

https://www.dangdaiyiyao.com/EN/ OR https://www.dangdaiyiyao.com/EN/Y2022/V29/I16/155

[1]	蔡佩佩，蔡小鸟，唐森森，等.二联药物方案对幽门螺杆菌阴性消化性溃疡患者临床症状评分及炎性细胞因子水平的影响[J].药物生物技术，2020，27（4）：345-347.
[2]	李宝玲，张建国，李东玲.温胃舒颗粒联合艾司奥美拉唑治疗胃溃疡的临床研究[J].现代药物与临床，2018，33（5）：1089-1092.
[3]	沈曙光，周守凤，郭凯.抗生素联合奥美拉唑治疗消化性溃疡的临床疗效[J].西北国防医学杂志，2019，40（4）：231-235.
[4]	刘亚文，刘红，吴静.胃黏膜保护机制与药物研究进展[J].临床药物治疗杂志，2018，16（10）：8-12.
[5]	中华消化杂志编委会.消化性溃疡诊断与治疗规范（2016年，西安）[J].中华消化杂志，2016，36（8）：508-513.
[6]	宋东升，叶云，胥雄阳.埃索美拉唑四联方案治疗胃溃疡的临床疗效与患者的外周血T 细胞亚群水平的关联性分析[J].现代免疫学，2018，38（1）：25-30.
[7]	费林立，何璐莎.奥美拉唑联合抗生素治疗对胃溃疡患者免疫功能及胃肠激素的影响[J].国际消化病杂志，2018，38（4）：272-275.
[8]	王开英，陈柯婷，毛炜，等.胃溃疡验方剂联合奥美拉唑治疗胃溃疡的疗效及对胃肠激素水平影响[J].中华中医药学刊，2019，37（10）：2526-2528.
[9]	刘慧，郁磊，张诒凤，等.替普瑞酮改良四联疗法治疗幽门螺旋杆菌阳性胃溃疡患者效果及对胃黏膜形态、TGF-β、Smad3、胃肠激素影响[J].临床误诊误治，2020，33（5）：38-43.
[10]	彭飞，商丹.复方猴头胶囊联合雷贝拉唑治疗胃溃疡的临床研究[J].现代药物与临床，2019，34（12）：3620-3623.
[11]	隋玉辉，丁洁.奥曲肽联合西咪替丁治疗肾综合征出血热并消化道出血的临床疗效分析[J].中国地方病防治杂志，2018，33（4）：458，461.
[12]	李竹林，赵瑛.高强度间歇性运动联合药物治疗溃疡性结肠炎疗效及对患者细胞因子水平影响研究[J].陕西医学杂志，2019，48（7）：909-912.
[13]	杜学芳，马尚超，张彩凤，等.芪倍合剂联合美沙拉嗪对活动期溃疡性结肠炎患者Th17、Treg 细胞及其相关细胞因子水平的影响[J].药物评价研究，2020，43（11）：2254-2258.
[14]	冯媛，刘欣，史海涛，等.幽门螺杆菌感染对溃疡性结肠炎患者炎性细胞因子水平和肠道菌群含量的影响[J].世界临床药物，2019，40（5）：334-339.
[15]	张曼，高炳霞，齐颖，等.依卡倍特钠联合常规四联疗法对幽门螺杆菌阳性慢性萎缩性胃炎的疗效观察[J].现代消化及介入诊疗，2020，25（1）：76-79.